Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Gains from Investment Securities (2018 - 2019)

Historic Gains from Investment Securities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $71000.0.

  • DiaMedica Therapeutics' Gains from Investment Securities rose 923.08% to $71000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $75000.0, marking a year-over-year decrease of 2788.46%. This contributed to the annual value of $30000.0 for FY2024, which is 40000.0% up from last year.
  • As of Q4 2019, DiaMedica Therapeutics' Gains from Investment Securities stood at $71000.0, which was up 923.08% from $1000.0 recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Gains from Investment Securities registered a high of $71000.0 during Q4 2019, and its lowest value of $1000.0 during Q2 2019.